Insiders · Profile

Matsuda Masaru

See Remarks at Arcutis Biotherapeutics. Filing since 2 Jun 2022. CIK 0001798679

Company

Date

Role

Action

Shares

Amount

Of holding

ARQT Arcutis Biotherapeutics, Inc.

16 Sep 2026

See Remarks

Sold on a plan

3,674

$91.85K

3.2%

ARQT Arcutis Biotherapeutics, Inc.

8 Sep 2026

See Remarks

Sold on a plan

9,989

$249.99K

7.9%

ARQT Arcutis Biotherapeutics, Inc.

3 Aug 2026

See Remarks

Sold on a plan

1,230

$32.12K

1.0%

ARQT Arcutis Biotherapeutics, Inc.

4 May 2026

See Remarks

Sold on a plan

8,256

$192.42K

6.1%

ARQT Arcutis Biotherapeutics, Inc.

2 Mar 2026

See Remarks

Sold on a plan

8,733

$220.94K

6.0%

ARQT Arcutis Biotherapeutics, Inc.

27 Feb 2026

See Remarks

Sold on a plan

3,325

$92.93K

2.3%

ARQT Arcutis Biotherapeutics, Inc.

2 Feb 2026

See Remarks

Sold on a plan

40,638

$1.03M

27.0%

ARQT Arcutis Biotherapeutics, Inc.

1 Dec 2025

See Remarks

Sold on a plan

1,657

$50.09K

1.1%

ARQT Arcutis Biotherapeutics, Inc.

19 Nov 2025

See Remarks

Sold on a plan

2,550

$72.14K

1.7%

ARQT Arcutis Biotherapeutics, Inc.

3 Nov 2025

See Remarks

Sold on a plan

7,208

$178.16K

4.5%

ARQT Arcutis Biotherapeutics, Inc.

4 Sep 2025

See Remarks

Sold on a plan

36,130

$583.72K

18.3%

ARQT Arcutis Biotherapeutics, Inc.

4 Aug 2025

See Remarks

Sold on a plan

6,330

$90.69K

3.1%

ARQT Arcutis Biotherapeutics, Inc.

28 May 2025

See Remarks

Sold on a plan

1,800

$24.81K

0.9%

ARQT Arcutis Biotherapeutics, Inc.

2 May 2025

See Remarks

Sold on a plan

5,030

$76.45K

2.4%

ARQT Arcutis Biotherapeutics, Inc.

3 Mar 2025

See Remarks

Sold on a plan

3,263

$42.52K

1.5%

ARQT Arcutis Biotherapeutics, Inc.

3 Feb 2025

See Remarks

Sold on a plan

8,338

$105.89K

4.5%

ARQT Arcutis Biotherapeutics, Inc.

30 Nov 2024

See Remarks

Bought

1,657

$11.77K

0.9%

ARQT Arcutis Biotherapeutics, Inc.

19 Nov 2024

See Remarks

Sold on a plan

1,775

$17.19K

1.0%

ARQT Arcutis Biotherapeutics, Inc.

4 Nov 2024

See Remarks

Sold on a plan

5,015

$43.55K

2.7%

ARQT Arcutis Biotherapeutics, Inc.

2 Aug 2024

See Remarks

Sold on a plan

5,220

$47.06K

2.8%

ARQT Arcutis Biotherapeutics, Inc.

31 May 2024

See Remarks

Bought

4,000

$6.77K

2.2%

ARQT Arcutis Biotherapeutics, Inc.

28 May 2024

See Remark

Sold on a plan

1,775

$15.99K

0.9%

ARQT Arcutis Biotherapeutics, Inc.

2 May 2024

See Remark

Sold on a plan

5,016

$43.83K

2.6%

ARQT Arcutis Biotherapeutics, Inc.

4 Mar 2024

See Remark

Sold on a plan

3,760

$41.82K

1.9%

ARQT Arcutis Biotherapeutics, Inc.

21 Nov 2023

See Remark

Sold at will

1,850

$3.66K

3.8%

ARQT Arcutis Biotherapeutics, Inc.

31 May 2023

See Remark

Sold at will

1,830

$14.28K

4.2%

ARQT Arcutis Biotherapeutics, Inc.

2 Mar 2023

See Remarks

Sold, plan not stated

1,434

$22.70K

7.3%

ARQT Arcutis Biotherapeutics, Inc.

21 Nov 2022

See Remark

Sold, plan not stated

1,720

$31.29K

8.1%

ARQT Arcutis Biotherapeutics, Inc.

2 Jun 2022

SVP and General Counsel

Sold, plan not stated

1,795

$35.42K

9.9%

29 decisions on file.